| Epigenetic mechanisms as a new approach in cancer treatment: An updated review M Fardi, S Solali, MF Hagh Genes & diseases 5 (4), 304-311, 2018 | 185 | 2018 |
| Toll-like receptors as a key regulator of mesenchymal stem cell function: an up-to-date review S Shirjang, B Mansoori, S Solali, MF Hagh, K Shamsasenjan Cellular Immunology 315, 1-10, 2017 | 105 | 2017 |
| DNA methylation pattern as important epigenetic criterion in cancer M Ghavifekr Fakhr, M Farshdousti Hagh, D Shanehbandi, B Baradaran Genetics research international 2013 (1), 317569, 2013 | 101 | 2013 |
| The crucial role of ZEB2: from development to epithelial‐to‐mesenchymal transition and cancer complexity M Fardi, M Alivand, B Baradaran, M Farshdousti Hagh, S Solali Journal of cellular physiology 234 (9), 14783-14799, 2019 | 92 | 2019 |
| Different methylation patterns of RUNX2, OSX, DLX5 and BSP in osteoblastic differentiation of mesenchymal stem cells MF Hagh, M Noruzinia, Y Mortazavi, M Soleimani, S Kaviani, S Abroun, ... Cell Journal (Yakhteh) 17 (1), 71, 2015 | 75 | 2015 |
| Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells N Saki, S Abroun, MF Hagh, F Asgharei Cell Journal (Yakhteh) 13 (3), 131, 2011 | 69 | 2011 |
| Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies MF Hagh, N Saki, E Mortaz, M Soleimani, F Rahim International journal of hematology-oncology and stem cell research 7 (1), 15, 2013 | 48 | 2013 |
| Gene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cells F Marofi, G Vahedi, S Solali, M Alivand, S Salarinasab, ... Journal of cellular physiology 234 (5), 6230-6243, 2019 | 44 | 2019 |
| ROR2 promoter methylation change in osteoblastic differentiation of mesenchymal stem cells G Tarfiei, M Noruzinia, M Soleimani, S Kaviani, MM Maymand, MF Hagh, ... Cell Journal (Yakhteh) 13 (1), 11, 2011 | 44 | 2011 |
| Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL A Hassanzadeh, M Farshdousti Hagh, MR Alivand, AAM Akbari, ... Journal of cellular physiology 233 (10), 6470-6485, 2018 | 43 | 2018 |
| The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia R Saraei, M Soleimani, AAM Akbari, MF Hagh, A Hassanzadeh, S Solali Biomedicine & Pharmacotherapy 107, 1010-1019, 2018 | 41 | 2018 |
| Investigation of BAX and BCL2 expression and apoptosis in a resveratrol-and prednisolone-treated human T-ALL cell line, CCRF-CEM T Khanzadeh, MF Hagh, M Talebi, B Yousefi, A Azimi, B Baradaran Blood research 53 (1), 53, 2018 | 41 | 2018 |
| Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia M Rahmani, M Talebi, MF Hagh, AAH Feizi, S Solali Biomedicine & Pharmacotherapy 97, 1493-1500, 2018 | 38 | 2018 |
| TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies A Naimi, AA Movassaghpour, MF Hagh, M Talebi, A Entezari, ... Biomedicine & Pharmacotherapy 98, 566-576, 2018 | 37 | 2018 |
| Quercetin sensitizes human myeloid leukemia KG‐1 cells against TRAIL‐induced apoptosis A Naimi, A Entezari, MF Hagh, A Hassanzadeh, R Saraei, S Solali Journal of cellular physiology 234 (8), 13233-13241, 2019 | 35 | 2019 |
| Mesenchymal stem cells as the game‐changing tools in the treatment of various organs disorders: Mirage or reality? F Marofi, G Vahedi, A Hasanzadeh, S Salarinasab, P Arzhanga, ... Journal of Cellular Physiology 234 (2), 1268-1288, 2019 | 32 | 2019 |
| Time-and concentration-dependent effects of resveratrol on miR 15a and miR16-1 expression and apoptosis in the CCRF-CEM acute lymphoblastic leukemia cell line A Azimi, MF Hagh, M Talebi, B Yousefi, B Baradaran, AA Movassaghpour, ... Asian Pacific Journal of Cancer Prevention 16 (15), 6463-6468, 2015 | 31 | 2015 |
| Epigenetic mechanisms are behind the regulation of the key genes associated with the osteoblastic differentiation of the mesenchymal stem cells: The role of zoledronic acid on … F Marofi, A Hassanzadeh, S Solali, G Vahedi, R Mousavi Ardehaie, ... Journal of cellular physiology 234 (9), 15108-15122, 2019 | 28 | 2019 |
| Double sword role of EZH2 in leukemia S Safaei, B Baradaran, MF Hagh, MR Alivand, M Talebi, T Gharibi, ... Biomedicine & Pharmacotherapy 98, 626-635, 2018 | 26 | 2018 |
| Molecular Mechanisms of hemoglobin F induction MF Hagh, AD Fard, N Saki, M Shahjahani, S Kaviani International Journal of Hematology-Oncology and Stem Cell Research, 5-9, 2011 | 24 | 2011 |
